Currently FDA/PI staining is the standard assessment of human pancreatic islet viability with suitability for transplantation when viability score is above 70%.
FDA/PI staining is currently the gold standard assessment of human pancreatic islet viability and its potential for transplantation, with a viability threshold of above 70%.